鲁抗医药：非那雄胺片获得药品注册证书

Core Viewpoint - The announcement indicates that LuKang Pharmaceutical's subsidiary, Sait Company, has received a drug registration certificate for Finasteride tablets from the National Medical Products Administration, marking it as a generic drug approved under the new registration category 4, which is considered to have passed the consistency evaluation of quality and efficacy [1] Group 1 - LuKang Pharmaceutical's subsidiary, Sait Company, has been granted a drug registration certificate for Finasteride tablets [1] - The approval is categorized as a generic drug under the new registration classification 4 [1] - The drug is recognized as having met the standards for quality and efficacy consistency evaluation [1]